Piehealthcare
Connecting Clinical Expertise with AI
Driving healthcare innovation through clinical insight and AI technology.
Pushing the boundaries of medical AI with the DOCTOR EYE X-Series.
Pushing the boundaries of medical AI with the DOCTOR EYE X-Series.
Major vision-threatening ophthalmic conditions (Macular Degeneration, Diabetic Retinopathy, Epiretinal Membrane, Glaucoma)
Cerebral Aneurysm (A weakened, bulging spot in a brain artery that can cause a brain hemorrhage)
ADHD (Attention Deficit Hyperactivity Disorder)
Cerebrovascular Stenosis (Narrowing of the intracranial arteries or carotid arteries)
The DOCTOR EYE series comprises X-EYE, X-ANGIO, X-ADHD, and X-ECAS. Utilizing specialized AI analysis models designed for each condition, it screens for critical health risks, including diabetic retinopathy, macular degeneration, glaucoma, epiretinal membrane, cerebral aneurysm, ADHD, and cerebrovascular stenosis.
Captured fundus images are processed through condition-specific AI models to provide actionable insights for healthcare professionals. Rather than replacing a definitive diagnosis, DOCTOR EYE serves as a primary AI screening system for critical conditions, aiding in the early detection of patients who require further evaluation and specialized care.
Push the boundaries of fundus medical AI
*Expected Launch in 2027
Push the boundaries of fundus medical AI
Piehealthcare
Driving healthcare innovation through clinical insight and AI technology.
DOCTOR EYE
Pushing the boundaries of AI-powered fundus analysis.
OUR SOLUTIONS
01
Major sight-threatening eye diseases
Macular degeneration, diabetic retinopathy, retinal tears, and glaucoma
02
Cerebral aneurysm
A bulge in a weakened area of a blood vessel wall in the brain
03
ADHD
Attention-deficit/hyperactivity disorder
04
Cerebrovascular stenosis
Narrowing of blood vessels in the brain or the carotid arteries
DOCTOR EYE Medical AI Solutions
The DOCTOR EYE series includes X-EYE, X-ANGIO, X-ADHD, and X-ECAS. Using AI models tailored to each condition, it screens for the risk of serious conditions, including diabetic retinopathy, macular degeneration, glaucoma, epiretinal membrane, cerebral aneurysm, ADHD, and cerebrovascular stenosis.
Each fundus image is analyzed by condition-specific AI models, with results presented for review by healthcare professionals. DOCTOR EYE is an AI system for first-line screening of serious conditions, designed to help identify patients who may need further testing or specialist care. It supports clinical assessment and does not replace a definitive diagnosis.
Piehealthcare's Strengths
An integrated medical AI technology platform delivering safe and precise analytics
Biomarker analysis images
(Ophthalmic Analysis Segmentation Image System)
Advanced analysis technology for biomarkers including anatomical structures, blood vessels, and nerves within fundus images.
Accurately segments and analyzes features across 40 types of biomarkers in fundus photography.
(Cooperative Mixture-of-Experts)
Technology that highlights key focus areas analyzed by AI within fundus images using green markers.






Disentangling Co-occurring Retinal Pathologies with Saliency-Guided Sparse Expert Routing
A
Saliency-Guided Sparse MoE
framework designed to disentangle and independently diagnose
co-occurring retinal pathologies in fundus images.
Lesion-centric expert routing minimizes cross-disease interference,
achieving
0.912 mAUC and 0.653 mF1 on ODIR-2019
,
with an inference speed of
5.23 ms per image
.
Disentangling Co-occurring Retinal Pathologies with Saliency-Guided Sparse Expert Routing
Nagur Shareef Shaik, Jeongwoo Park, Yeong-Jin Kim, Jaeuk Jung, Hyunjung Oh, Dong Hye Ye
2026 IEEE International Workshop on Machine Learning for Signal Processing (MLSP)
World-leading Oculomics research conducted in collaboration with Seoul National University Hospital.
Piehealthcare collaborates with leading domestic and international institutions to advance technology development and research.
Piehealthcare's Strengths
Integrated Medical AI Platform Delivering Safe and Precise Analysis
Biomarker Analysis Images
(Ophthalmic Analysis Segmentation Image System)
Advanced biomarker analysis technology for fundus photography, covering anatomical structures, blood vessels, and neural features.
Identifies and analyzes 41 distinct biomarkers in fundus images.
(Cooperative Mixture-of-Experts)
A technology that visualizes which regions of the fundus photograph the AI primarily focused on for analysis using green markers.
A Clinical AI Framework for Retinal Disease Diagnosis with Explainable Fundus Image Analysis
This paper introduces a system that diagnoses 4 major retinal diseases through real-time fundus image analysis in a SaaS-based cloud environment
and presents visual diagnostic rationale for AI using Grad-CAM technology.
REMEDIS: A Clinical AI Framework for Retinal Disease Diagnosis with Explainable Fundus Image Analysis
Youngkyu Lee¹, Jinho Lee¹, Youngdae Jo¹, Jeongwoo Park¹,²
Disentangling Co-occurring Retinal Pathologies with Saliency-Guided Sparse Expert Routing
A Saliency-Guided Sparse MoE framework designed to disentangle and independently diagnose co-occurring retinal pathologies in fundus images. Lesion-centric expert routing minimizes cross-disease interference, achieving 0.912 mAUC and 0.653 mF1 on ODIR-2019, with an inference speed of 5.23 ms per image.
Disentangling Co-occurring Retinal Pathologies with Saliency-Guided Sparse Expert Routing
Nagur Shareef Shaik, Jeongwoo Park, Yeong-Jin Kim, Jaeuk Jung, Hyunjung Oh, Dong Hye Ye
2026 IEEE International Workshop on Machine Learning for Signal Processing (MLSP)
This is the world's largest Oculomics research initiative, conducted in collaboration with Seoul National University Hospital.
Piehealthcare collaborates with leading domestic and international institutions on technology development and research.
DOCTOR EYE X-SERIES
DOCTOR EYE X-EYE is an AI software solution that analyzes retinal fundus images within seconds to detect major ophthalmic conditions, including macular degeneration, diabetic retinopathy, glaucoma, and epiretinal membrane.
It empowers medical professionals to make faster, more accurate clinical decisions.
DOCTOR EYE SOLUTIONS
DOCTOR EYE X-EYE is an AI software solution that detects major ophthalmic diseases, including macular degeneration, diabetic retinopathy, glaucoma, and epiretinal membrane, within seconds by analyzing retinal images captured with a fundus camera.
It empowers healthcare professionals to make faster and more precise clinical decisions.
The DOCTOR EYE AI series delivers rapid and precise diagnostic analysis across various medical fields.
Select a product to view detailed specifications and technical information.
OCULOMICS RESEARCH
In Collaboration with Seoul National University Hospital
Retinal Fundus Images
MRI · MRA · CT · Ultrasound
Just seconds after imaging, DOCTOR EYE AI detects critical diseases.
Key Detected Conditions
Key Benefits
ON DEVICE l DOCTOR EYE
Achievements
AAAI 2026 Global Academic Achievements
Following its publication acceptance in an AAAI journal in October 2025, Piehealthcare officially presented "REMEDIS," an AI-based retinal diagnostic framework, at AAAI 2026 held in Singapore.
Milestones
Awards
Certifications



Patents
HIGHLIGHTS
RESEARCH HIGHLIGHT
Following the paper acceptance by an AAAI-affiliated journal in October 2025, Piehealthcare officially presented "REMEDIS", an AI-powered retinal diagnostics framework, at AAAI 2026 in Singapore.
Presented Paper / Framework
01REMEDIS: AI-Powered Retinal Diagnostics Framework
Key Technical Milestone
02Demonstrated Outstanding Zero-Shot Composed Image Retrieval (CIR) Performance
Milestones
Awards · Certifications · Patents
PIEHEALTHCARE HIGHLIGHTS
Commendation for Industrial R&D Advancement
2026.09.07 | Awarded by: Deputy Prime Minister and Minister of Science and ICT
Selected for Korea Frontier 1st Cohort
2025.11.07
Suwon Small and Medium Business Award (Management Innovation)
2025.10.28
Encouragement Award, Gyeonggi SME AI Transformation Best Practice Contest
2025.10.01
Grand Prize, SME Management Innovation Contest
2025.09.04 | Awarded by: Minister of SMEs and Startups
ISO 13485:2016 Medical Devices Quality Management System Certificate
ISO 27701:2025 Privacy Information Management System Certificate
ISO 27017:2015 Information Security Management System Certificate
ISO 27001:2022 Information Security Management System Certificate
Application No. 10-2025-0037931
Application No. 10-2025-0033129
(PP25-114)
Filing Date: 2024-08-27
Application No. 10-2025-0033129
(PP25-114)
Filing Date: 2025-03-14
Application No. 10-2025-0051915
(PP25-127)
Filing Date: 2025-04-21
Application No. 10-2025-0135358
Filing Date: 2025-09-19
Application No. 10-2025-0135359
(PP25-182)
Filing Date: 2025-09-19
Application No. 10-2025-0146765
Filing Date: 2025-10-13
Application No. 10-2026-0021647
Filing Date: 2026-02-16
Application No. 10-2026-0066875
Filing Date: 2026-04-10
Application No. 10-2026-0158424
Filing Date: 2026.09.15
Application No. PCT/KR2026/011000
International Filing Date: 2026-08-05
Application No. 10-2026-0178647
Filing Date: 2026.09.18
Application No. 10-2026-0187974
Filing Date: 2026.10.01
News & Updates
LEADERSHIP GROUP
Contact us
For inquiries regarding DOCTOR EYE, please contact us at contact@pie-healthcare.com.
Contact us
Phone
+82-31-252-7266/7
Address
Piehealthcare
PIEAI